Your browser doesn't support javascript.
loading
Curcumin combined with FAPαc vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-α in melanoma.
Jiang, Guan-Min; Xie, Wan-Ying; Wang, Hong-Sheng; Du, Jun; Wu, Bai-Ping; Xu, Wei; Liu, Hui-Fang; Xiao, Ping; Liu, Zhi-Gang; Li, Hong-Yan; Liu, Shuang-Quan; Yin, Wen-Jun; Zhang, Qiu-Gui; Liang, Jian-Ping; Huang, Hong-Jun.
Afiliación
  • Jiang GM; Department of Clinical Laboratory, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, PR China.
  • Xie WY; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
  • Wang HS; Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, PR China.
  • Du J; Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, PR China.
  • Wu BP; Department of Clinical Laboratory, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, PR China.
  • Xu W; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
  • Liu HF; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
  • Xiao P; Department of Clinical Laboratory, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, PR China.
  • Liu ZG; Department of Radiation Oncology, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, PR China.
  • Li HY; Department of Clinical Laboratory, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, PR China.
  • Liu SQ; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
  • Yin WJ; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
  • Zhang QG; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, 421001, PR China.
  • Liang JP; Department of Thoracic Surgery 2, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, PR China.
  • Huang HJ; Department of Clinical Laboratory, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, PR China.
Oncotarget ; 6(28): 25932-42, 2015 Sep 22.
Article en En | MEDLINE | ID: mdl-26305550
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Melanoma Experimental / Protocolos de Quimioterapia Combinada Antineoplásica / Gelatinasas / Indolamina-Pirrol 2,3,-Dioxigenasa / Transición Epitelial-Mesenquimal / Proteínas de la Membrana Límite: Animals Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Melanoma Experimental / Protocolos de Quimioterapia Combinada Antineoplásica / Gelatinasas / Indolamina-Pirrol 2,3,-Dioxigenasa / Transición Epitelial-Mesenquimal / Proteínas de la Membrana Límite: Animals Idioma: En Revista: Oncotarget Año: 2015 Tipo del documento: Article